<unk>  <unk>  is a condition where there is a frequent feeling of needing to urinate to a degree that it negatively affects a person's life. The frequent need to urinate may occur during the day, at night, or both. If there is loss of<unk>  control then it is known as urge incontinence. More than 40% of people with<unk>  have incontinence. Conversely, about 40% to 70% of urinary incontinence is due to<unk> .<unk>  is not life-threatening, but most people with the condition have problems for years. The cause of<unk>  is unknown. Risk factors include obesity, caffeine, and constipation. Poorly controlled diabetes, poor functional mobility, and chronic pelvic pain may worsen the symptoms. People often have the symptoms for a long time before seeking treatment and the condition is sometimes identified by caregivers. Diagnosis is based on a person's signs and symptoms and requires other problems such as urinary tract infections or neurological conditions to be excluded. The amount of urine passed during each urination is relatively small. Pain while urinating suggests that there is a problem other than<unk> . Specific treatment is not always required. If treatment is desired pelvic floor exercises,<unk>  training, and other behavioral methods are initially recommended. Weight loss in those who are overweight, decreasing caffeine consumption, and drinking moderate fluids, can also have benefits. Medications, typically of the anti-muscarinic type, are only recommended if other measures are not effective. They are no more effective than behavioral methods; however, they are associated with side effects, particularly in older people. Some non-invasive electrical stimulation methods appear effective while they are in use. Injections of botulinum toxin into the<unk>  is another option. Urinary catheters or surgery are generally not recommended. A diary to track problems can help determine whether treatments are working.<unk>  is estimated to occur in 7-27% of men and 9-43% of women. It becomes more common with age. Some studies suggest that the condition is more common in women, especially when associated with loss of<unk>  control. Economic costs of<unk>  were estimated in the United States at US$12.6 billion and 4.2 billion Euro in 2000.
Overactive bladder
Neurogenic bladder dysfunction
Underactive bladder
Urinary tract infection
Stress incontinence
Interstitial cystitis
Chronic prostatitis/chronic pelvic pain syndrome
Overflow incontinence